Bio-Techne (TECH) EBITDA Margin (2009 - 2026)
Bio-Techne (TECH) reported EBITDA Margin of 30.64% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 29.62 percentage points from 1.03% a year earlier but down 1.36 percentage points from the prior quarter.
Bio-Techne (TECH) EBITDA Margin (2009 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Bio-Techne posted EBITDA Margin of 28.74%, up 11.35 percentage points from FY2025.
- EBITDA Margin has a five-year change of -6.17 percentage points (FY2021 to FY2026).
- By fiscal year, EBITDA Margin came in at 17.40% in FY2025 (-10.08 pp), 27.47% in FY2024 (-8.26 pp), 35.73% in FY2023 (-0.23 pp) and 35.97% in FY2022 (+1.06 pp).
- Five-year quarterly EBITDA Margin spans a low of 1.03% in fiscal Q4 2025 and a high of 40.31% in fiscal Q4 2023.
- Year over year, EBITDA Margin has now increased in each of the last four quarters, with an average year-over-year change of +0.59 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was fiscal Q4 2026 (a gain of 29.62 percentage points); the low point was fiscal Q4 2025 (a drop of 23.11 percentage points).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at 32.00% (Q3 2026), 26.76% (Q2 2026) and 25.13% (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | Bio-Techne | 11.32 Bn | 10.53 Bn | 211.39 Mn | 30.64% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.64% |
| Mar 31, 2026 | 32.00% |
| Dec 31, 2025 | 26.76% |
| Sep 30, 2025 | 25.13% |
| Jun 30, 2025 | 1.03% |
| Mar 31, 2025 | 20.96% |
| Dec 31, 2024 | 25.08% |
| Sep 30, 2024 | 23.54% |
| Jun 30, 2024 | 24.14% |
| Mar 31, 2024 | 31.08% |
| Dec 31, 2023 | 24.14% |
| Sep 30, 2023 | 30.48% |
| Jun 30, 2023 | 40.31% |
| Mar 31, 2023 | 36.44% |
| Dec 31, 2022 | 34.83% |
| Sep 30, 2022 | 30.76% |
| Jun 30, 2022 | 36.93% |
| Mar 31, 2022 | 39.88% |
| Dec 31, 2021 | 32.48% |
| Sep 30, 2021 | 34.13% |
Bio-Techne EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TECH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TECH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TECH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();